Stocks To Watch: RIL, Paytm, Tata Power, HCL Tech, KPI Green, SJVN, Emcure Pharma, And Others

Stocks to Watch On November 18: Equity benchmarks extended their gains on Monday, with the Nifty rising for a sixth straight session and closing just below 26,013 amid a firm domestic tone. However, analysts cautioned that global cues—particularly heightened volatility in US markets—could influence sentiment in the days ahead.

“With Nifty approaching its previous swing high near 26,100, some resistance at higher levels cannot be ruled out. That said, the broader undertone remains positive,” said Ajit Mishra, SVP Research, Religare Broking.

Reliance Industries
Reliance Retail has signed an exclusive distribution pact with Germany’s cosnova Beauty to launch the ‘essence’ cosmetics brand in India.

Paytm SAIF III Mauritius, SAIF Partners and Elevation

Capital are likely to sell a combined 2% stake via a block deal, according to reports.

Tata Power
Tata Power Renewable Energy Ltd (TPREL) has completed commissioning NHPC’s 300 MW solar project under an EPC contract.

Emcure Pharma
Bain Capital’s BC Investments is expected to sell up to 2% of Emcure’s equity through a block deal, with a reported floor price of ₹1,296.51 per share.

HCL Tech
HCL Tech and Nvidia have launched an innovation lab in Santa Clara to help enterprises build and test real-world applications of physical AI and cognitive robotics.

JSW Energy
Pritesh Vinay has resigned as Director and will exit the Board to pursue opportunities outside the JSW Group.

WPIL
WPIL’s South African subsidiary has won a ₹426 crore contract from Matla a Metsi Joint Venture, with completion targeted in four years.

KEC International
KEC has secured new orders worth ₹1,016 crore across sectors, including fresh contracts for its Buildings & Factories business.

KPI Green, SJVN
KPI Green Energy has signed agreements with SJVN Ltd for a ₹696.50 crore project to develop a 200 MW AC solar plant at the GIPCL Renewable Energy Park in Khavda, Gujarat.

AstraZeneca Pharma, Sun Pharma
AstraZeneca has entered into a second brand partnership with Sun Pharma for Sodium Zirconium Cyclosilicate (SZC) in India.

Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.